Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


24.04.2017

2 Ann Oncol
2 Ann Surg Oncol
3 BMC Cancer
4 Br J Cancer
2 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
4 Breast Cancer Res Treat
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
2 Cancer Res
4 Carcinogenesis
3 Clin Breast Cancer
1 Clin Cancer Res
3 Eur J Cancer
2 Gene
1 J Clin Oncol
4 J Natl Cancer Inst
1 Oncogene
1 Oncology (Williston Park)
1 Pathology
1 PLoS Med
7 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. WEIN L, Savas P, Van Geelan C, Caramia F, et al
    FGFR2 amplification in metastatic hormone positive breast cancer and response to an mTOR inhibitor.
    Ann Oncol. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format    

  2. CURIGLIANO G, Goldhirsch A
    Dual HER2 inhibition and pathological complete response in early breast cancer: increasing success of treatment by improving patient selection.
    Ann Oncol. 2017;28:441-443.
    PubMed     Text format    


    Ann Surg Oncol

  3. MAMTANI A, Patil S, Stempel M, Morrow M, et al
    Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer.
    Ann Surg Oncol. 2017 Apr 20. doi: 10.1245/s10434-017-5866.
    PubMed     Text format     Abstract available

  4. DONOVAN CA, Bao J, Gangi A, Amersi F, et al
    Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Apr 17. doi: 10.1245/s10434-017-5856.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. SETYOWIBOWO H, Sijbrandij M, Iskandarsyah A, Hunfeld JAM, et al
    A protocol for a cluster-randomized controlled trial of a self-help psycho-education programme to reduce diagnosis delay in women with breast cancer symptoms in Indonesia.
    BMC Cancer. 2017;17:284.
    PubMed     Text format     Abstract available

  6. LABOVSKY V, Martinez LM, Davies KM, de Lujan Calcagno M, et al
    Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer.
    BMC Cancer. 2017;17:280.
    PubMed     Text format     Abstract available

  7. CHAN S, Chen JH, Li S, Chang R, et al
    Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants.
    BMC Cancer. 2017;17:274.
    PubMed     Text format     Abstract available


    Br J Cancer

  8. TRAN WT, Gangeh MJ, Sannachi L, Chin L, et al
    Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.
    Br J Cancer. 2017 Apr 18. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  9. MESCI A, Huang X, Taeb S, Jahangiri S, et al
    Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.
    Br J Cancer. 2017 Apr 18. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  10. ROMAN M, Quintana MJ, Ferrer J, Sala M, et al
    Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.
    Br J Cancer. 2017 Apr 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  11. KWIATKOWSKI F, Mouret-Reynier MA, Duclos M, Bridon F, et al
    Long-term improvement of breast cancer survivors' quality of life by a 2-week group physical and educational intervention: 5-year update of the 'PACThe' trial.
    Br J Cancer. 2017 Apr 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer

  12. INARI H, Suganuma N, Kawachi K, Yoshida T, et al
    Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.
    Breast Cancer. 2017 Apr 19. doi: 10.1007/s12282-017-0774.
    PubMed     Text format     Abstract available

  13. GHEYBI MK, Farrokhi S, Ravanbod MR, Ostovar A, et al
    The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Breast Cancer. 2017 Apr 20. doi: 10.1007/s12282-017-0775.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  14. KOLECK TA, Bender CM, Clark BZ, Ryan CM, et al
    An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
    Breast Cancer (Dove Med Press). 2017;9:95-110.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  15. CARTER EP, Gopsill JA, Gomm JJ, Jones JL, et al
    A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer.
    Breast Cancer Res. 2017;19:50.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  16. DUDENKOV TM, Ingle JN, Buzdar AU, Robson ME, et al
    SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
    Breast Cancer Res Treat. 2017 Apr 20. doi: 10.1007/s10549-017-4243.
    PubMed     Text format     Abstract available

  17. ABDEL-RAHMAN O
    Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis.
    Breast Cancer Res Treat. 2017 Apr 17. doi: 10.1007/s10549-017-4244.
    PubMed     Text format     Abstract available

  18. SOUCISE A, Vaughn C, Thompson CL, Millen AE, et al
    Sleep quality, duration, and breast cancer aggressiveness.
    Breast Cancer Res Treat. 2017 Apr 17. doi: 10.1007/s10549-017-4245.
    PubMed     Text format     Abstract available

  19. REYES ME, Fujii T, Branstetter D, Krishnamurthy S, et al
    Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
    Breast Cancer Res Treat. 2017 Apr 17. doi: 10.1007/s10549-017-4233.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  20. WILLIAMS LA, Olshan AF, Hong CC, Bandera EV, et al
    Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium.
    Cancer Epidemiol Biomarkers Prev. 2017.
    PubMed     Text format     Abstract available


    Cancer Lett

  21. LUI AJ, Geanes ES, Ogony J, Behbod F, et al
    IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
    Cancer Lett. 2017 Apr 12. pii: S0304-3835(17)30235.
    PubMed     Text format     Abstract available


    Cancer Res

  22. SAFONOV A, Jiang T, Bianchini G, Gyorffy B, et al
    Immune gene expression is associated with genomic aberrations in breast cancer.
    Cancer Res. 2017 Apr 20. pii: canres.3478.2016.
    PubMed     Text format     Abstract available

  23. LU K, Alcivar AL, Ma J, Foo TK, et al
    NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction.
    Cancer Res. 2017 Apr 17. pii: canres.2204.2016.
    PubMed     Text format     Abstract available


    Carcinogenesis

  24. DESHMUKH SK, Srivastava SK, Tyagi N, Ahmad A, et al
    Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.
    Carcinogenesis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. SAUER SJ, Tarpley M, Shah I, Save AV, et al
    Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.
    Carcinogenesis. 2017;38:252-260.
    PubMed     Text format     Abstract available

  26. YANG R, Stocker S, Schott S, Heil J, et al
    The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
    Carcinogenesis. 2017;38:312-320.
    PubMed     Text format     Abstract available

  27. HAN MR, Zheng W, Cai Q, Gao YT, et al
    Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
    Carcinogenesis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  28. GINTER PS, McIntire PJ, Cui X, Irshaid L, et al
    Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(17)30012.
    PubMed     Text format     Abstract available

  29. MENDEZ-HERNANDEZ A, Gallegos-Arreola MP, Moreno-Macias H, Espinosa Fematt J, et al
    LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer.
    Clin Breast Cancer. 2017 Mar 22. pii: S1526-8209(16)30246.
    PubMed     Text format     Abstract available

  30. PIVO S, Montes J, Schwartz S, Chun J, et al
    Breast Cancer Risk Assessment and Screening in Transgender Patients.
    Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30233.
    PubMed     Text format    


    Clin Cancer Res

  31. WEERTS MJA, Hollestelle A, Sieuwerts AM, Foekens JA, et al
    Low Tumor Mitochondrial DNA Content is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-based Chemotherapy.
    Clin Cancer Res. 2017 Apr 18. pii: clincanres.0032.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  32. VAN ERKELENS A, Sie AS, Manders P, Visser A, et al
    Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress.
    Eur J Cancer. 2017;78:45-52.
    PubMed     Text format     Abstract available

  33. ENGELHARDT EG, van den Broek AJ, Linn SC, Wishart GC, et al
    Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
    Eur J Cancer. 2017;78:37-44.
    PubMed     Text format     Abstract available

  34. MANNU GS, Dodwell D
    Making progress in early breast cancer: Taking time or accepting risk?
    Eur J Cancer. 2017;78:24-27.
    PubMed     Text format     Abstract available


    Gene

  35. SULTANA R, Kataki AC, Borthakur BB, Basumatary TK, et al
    Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Gene. 2017 Apr 14. pii: S0378-1119(17)30272-X. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available

  36. HUANG H, Li C, Ren G
    Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
    Gene. 2017 Apr 12. pii: S0378-1119(17)30246-9. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    J Clin Oncol

  37. MALY RC, Liang LJ, Liu Y, Griggs JJ, et al
    Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors.
    J Clin Oncol. 2017 Apr 18:JCO2016689497. doi: 10.1200/JCO.2016.68.9497.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst


  38. Restarting Adjuvant Hormone Therapy Improves Breast Cancer Outcomes.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  39. HE W, Smedby KE, Fang F, Olsson H, et al
    Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  40. Different Breast Cancer Treatment Options Vary Widely in their Cost-Effectiveness.
    J Natl Cancer Inst. 2017;109:1-2.
    PubMed     Text format    


  41. Night Shift Work and Breast Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    Oncogene

  42. JALAGUIER S, Teyssier C, Nait Achour T, Lucas A, et al
    Complex regulation of LCoR signaling in breast cancer cells.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  43. COPUR MS, Ramaekers R, Gauchan D, Crockett D, et al
    Synchronous Bilateral Breast Cancer With Discordant Histology.
    Oncology (Williston Park). 2017;31:274-7.
    PubMed     Text format    


    Pathology

  44. ARMES JE, Galbraith C, Gray J, Taylor K, et al
    The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.
    Pathology. 2017;49:267-270.
    PubMed     Text format     Abstract available


    PLoS Med

  45. SAVAS P, Teo ZL, Lefevre C, Flensburg C, et al
    Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
    PLoS Med. 2017;14:e1002302.
    PubMed     Text format     Abstract available


    PLoS One

  46. BOYD A, Stoodley P, Richards D, Hui R, et al
    Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    PLoS One. 2017;12:e0175544.
    PubMed     Text format     Abstract available

  47. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2017;12:e0175323.
    PubMed     Text format     Abstract available

  48. GRONBERG M, Ahlin C, Naeser Y, Janson ET, et al
    Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.
    PLoS One. 2017;12:e0176059.
    PubMed     Text format     Abstract available

  49. AHN SG, Lee JH, Lee HW, Jeon TJ, et al
    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    PLoS One. 2017;12:e0175048.
    PubMed     Text format     Abstract available

  50. CASTLE J, Morris K, Pritchard S, Kirwan CC, et al
    Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    PLoS One. 2017;12:e0175647.
    PubMed     Text format     Abstract available

  51. EL GUERRAB A, Cayre A, Kwiatkowski F, Privat M, et al
    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.
    PLoS One. 2017;12:e0175960.
    PubMed     Text format     Abstract available

  52. TIRAN V, Stanzer S, Heitzer E, Meilinger M, et al
    Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    PLoS One. 2017;12:e0175223.
    PubMed     Text format     Abstract available


    Radiology

  53. TUCKER L, Gilbert FJ, Astley SM, Dibden A, et al
    Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?
    Radiology. 2017 Mar 13:151936. doi: 10.1148/radiol.2017151936.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: